Management of severe respiratory tract disease caused by human respiratory syncytial virus and Streptococcus pneumoniae in captive chimpanzees (Pan troglodytes)

J Zoo Wildl Med. 2013 Mar;44(1):105-15. doi: 10.1638/1042-7260-44.1.105.

Abstract

Chimpanzees (Pan troglodytes) are susceptible to many viral and bacterial pathogens of human origin. This case series reports an acute outbreak of respiratory disease due to human respiratory syncytial virus and Streptococcus pneumoniae in a single group of 30 captive chimpanzees. Both pathogens are potentially zoonotic. The diagnosis was made antemortem and enabled a targeted response to the outbreak; but it more importantly, prompted improvements to the disease surveillance, biosecurity for risk mitigation and risk communication protocols within the zoo. A defined zoonotic disease risk communication pathway provides a model for management and compliance requirements for other collections.

MeSH terms

  • Animals
  • Animals, Zoo
  • Anti-Bacterial Agents / therapeutic use
  • Ape Diseases / drug therapy
  • Ape Diseases / microbiology*
  • Ape Diseases / mortality
  • Ape Diseases / virology
  • Disease Outbreaks / veterinary
  • Female
  • Male
  • Pan troglodytes*
  • Pneumococcal Infections / drug therapy
  • Pneumococcal Infections / microbiology
  • Pneumococcal Infections / mortality
  • Pneumococcal Infections / pathology
  • Pneumococcal Infections / veterinary*
  • Respiratory Syncytial Virus Infections / mortality
  • Respiratory Syncytial Virus Infections / pathology
  • Respiratory Syncytial Virus Infections / veterinary*
  • Respiratory Syncytial Virus Infections / virology
  • Respiratory Syncytial Virus, Human / isolation & purification*
  • Streptococcus pneumoniae / isolation & purification*

Substances

  • Anti-Bacterial Agents